122 related articles for article (PubMed ID: 37865290)
1. A New Set of in Silico Tools to Support the Interpretation of ATM Missense Variants Using Graphical Analysis.
Porras LM; Padilla N; Moles-Fernández A; Feliubadaló L; Santamariña-Pena M; Sánchez AT; López-Novo A; Blanco A; de la Hoya M; Molina IJ; Osorio A; Pineda M; Rueda D; Ruiz-Ponte C; Vega A; Lázaro C; Díez O; Gutiérrez-Enríquez S; de la Cruz X
J Mol Diagn; 2024 Jan; 26(1):17-28. PubMed ID: 37865290
[TBL] [Abstract][Full Text] [Related]
2. A Collaborative Effort to Define Classification Criteria for ATM Variants in Hereditary Cancer Patients.
Feliubadaló L; Moles-Fernández A; Santamariña-Pena M; Sánchez AT; López-Novo A; Porras LM; Blanco A; Capellá G; de la Hoya M; Molina IJ; Osorio A; Pineda M; Rueda D; de la Cruz X; Diez O; Ruiz-Ponte C; Gutiérrez-Enríquez S; Vega A; Lázaro C
Clin Chem; 2021 Mar; 67(3):518-533. PubMed ID: 33280026
[TBL] [Abstract][Full Text] [Related]
3. Involvement of ATM missense variants and mutations in a series of unselected breast cancer cases.
Rodriguez C; Vallès H; Causse A; Johannsdottir V; Eliaou JF; Theillet C
Genes Chromosomes Cancer; 2002 Feb; 33(2):141-9. PubMed ID: 11793440
[TBL] [Abstract][Full Text] [Related]
4. BRCA1/2 missense mutations and the value of in-silico analyses.
Sadowski CE; Kohlstedt D; Meisel C; Keller K; Becker K; Mackenroth L; Rump A; Schröck E; Wimberger P; Kast K
Eur J Med Genet; 2017 Nov; 60(11):572-577. PubMed ID: 28807866
[TBL] [Abstract][Full Text] [Related]
5. Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.
Renault AL; Mebirouk N; Fuhrmann L; Bataillon G; Cavaciuti E; Le Gal D; Girard E; Popova T; La Rosa P; Beauvallet J; Eon-Marchais S; Dondon MG; d'Enghien CD; Laugé A; Chemlali W; Raynal V; Labbé M; Bièche I; Baulande S; Bay JO; Berthet P; Caron O; Buecher B; Faivre L; Fresnay M; Gauthier-Villars M; Gesta P; Janin N; Lejeune S; Maugard C; Moutton S; Venat-Bouvet L; Zattara H; Fricker JP; Gladieff L; Coupier I; ; ; ; Chenevix-Trench G; Hall J; Vincent-Salomon A; Stoppa-Lyonnet D; Andrieu N; Lesueur F
Breast Cancer Res; 2018 Apr; 20(1):28. PubMed ID: 29665859
[TBL] [Abstract][Full Text] [Related]
6. Rare variants in the ATM gene and risk of breast cancer.
Goldgar DE; Healey S; Dowty JG; Da Silva L; Chen X; Spurdle AB; Terry MB; Daly MJ; Buys SM; Southey MC; Andrulis I; John EM; ; ; Khanna KK; Hopper JL; Oefner PJ; Lakhani S; Chenevix-Trench G
Breast Cancer Res; 2011 Jul; 13(4):R73. PubMed ID: 21787400
[TBL] [Abstract][Full Text] [Related]
7. Tailoring the American College of Medical Genetics and Genomics and the Association for Molecular Pathology Guidelines for the Interpretation of Sequenced Variants in the
Muiño-Mosquera L; Steijns F; Audenaert T; Meerschaut I; De Paepe A; Steyaert W; Symoens S; Coucke P; Callewaert B; Renard M; De Backer J
Circ Genom Precis Med; 2018 Jun; 11(6):e002039. PubMed ID: 29875124
[TBL] [Abstract][Full Text] [Related]
8. Performance of in silico prediction tools for the classification of rare BRCA1/2 missense variants in clinical diagnostics.
Ernst C; Hahnen E; Engel C; Nothnagel M; Weber J; Schmutzler RK; Hauke J
BMC Med Genomics; 2018 Mar; 11(1):35. PubMed ID: 29580235
[TBL] [Abstract][Full Text] [Related]
9. Minigene-based splicing analysis and ACMG/AMP-based tentative classification of 56 ATM variants.
Bueno-Martínez E; Sanoguera-Miralles L; Valenzuela-Palomo A; Esteban-Sánchez A; Lorca V; Llinares-Burguet I; Allen J; García-Álvarez A; Pérez-Segura P; Durán M; Easton DF; Devilee P; Vreeswijk MP; de la Hoya M; Velasco-Sampedro EA
J Pathol; 2022 Sep; 258(1):83-101. PubMed ID: 35716007
[TBL] [Abstract][Full Text] [Related]
10. Uncovering variable neoplasms between ATM protein-truncating and common missense variants using 394 694 UK Biobank exomes.
Jiang X; O'Neill A; Smith KR; Lai Z; Carss K; Wang Q; Petrovski S
Genes Chromosomes Cancer; 2022 Sep; 61(9):523-529. PubMed ID: 35394676
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of ATM variants in a high risk cohort provides insight into missing heritability.
Baughan SL; Darwiche F; Tainsky MA
Cancer Genet; 2022 Jun; 264-265():40-49. PubMed ID: 35354106
[TBL] [Abstract][Full Text] [Related]
12. Cancer risks associated with heterozygous ATM loss of function and missense pathogenic variants based on multigene panel analysis.
Laitman Y; Nielsen SM; Bernstein-Molho R; Heald B; Hatchell KE; Esplin ED; Friedman E
Breast Cancer Res Treat; 2022 Nov; 196(2):355-361. PubMed ID: 36094610
[TBL] [Abstract][Full Text] [Related]
13. The relationship between twenty missense ATM variants and breast cancer risk: the Multiethnic Cohort.
Bretsky P; Haiman CA; Gilad S; Yahalom J; Grossman A; Paglin S; Van Den Berg D; Kolonel LN; Skaliter R; Henderson BE
Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):733-8. PubMed ID: 12917204
[TBL] [Abstract][Full Text] [Related]
14. Rare germline ATM variants of uncertain significance in chronic lymphocytic leukaemia and other cancers.
Petrackova A; Savara J; Turcsanyi P; Gajdos P; Papajik T; Kriegova E
Br J Haematol; 2022 Nov; 199(3):371-381. PubMed ID: 36029002
[TBL] [Abstract][Full Text] [Related]
15. ATM Variants in Breast Cancer: Implications for Breast Radiation Therapy Treatment Recommendations.
McDuff SGR; Bellon JR; Shannon KM; Gadd MA; Dunn S; Rosenstein BS; Ho AY
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1373-1382. PubMed ID: 33545302
[TBL] [Abstract][Full Text] [Related]
16. Ataxia-telangiectasia gene (
Jerzak KJ; Mancuso T; Eisen A
Curr Oncol; 2018 Apr; 25(2):e176-e180. PubMed ID: 29719442
[TBL] [Abstract][Full Text] [Related]
17. Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer.
Tavtigian SV; Oefner PJ; Babikyan D; Hartmann A; Healey S; Le Calvez-Kelm F; Lesueur F; Byrnes GB; Chuang SC; Forey N; Feuchtinger C; Gioia L; Hall J; Hashibe M; Herte B; McKay-Chopin S; Thomas A; Vallée MP; Voegele C; Webb PM; Whiteman DC; ; ; ; Sangrajrang S; Hopper JL; Southey MC; Andrulis IL; John EM; Chenevix-Trench G
Am J Hum Genet; 2009 Oct; 85(4):427-46. PubMed ID: 19781682
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a Pathogenic Variant rs139379666 (p. P2974L) in
Guo X; Lin W; Bai M; Li H; Wen W; Zeng C; Chen Z; He J; Chen J; Cai Q; Long J; Jia WH; Shu XO; Zheng W
Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1308-1315. PubMed ID: 31160347
[TBL] [Abstract][Full Text] [Related]
19. A novel pathogenic variant in an Iranian Ataxia telangiectasia family revealed by next-generation sequencing followed by in silico analysis.
Tabatabaiefar MA; Alipour P; Pourahmadiyan A; Fattahi N; Shariati L; Golchin N; Mohammadi-Asl J
J Neurol Sci; 2017 Aug; 379():212-216. PubMed ID: 28716242
[TBL] [Abstract][Full Text] [Related]
20. Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study.
Damiola F; Pertesi M; Oliver J; Le Calvez-Kelm F; Voegele C; Young EL; Robinot N; Forey N; Durand G; Vallée MP; Tao K; Roane TC; Williams GJ; Hopper JL; Southey MC; Andrulis IL; John EM; Goldgar DE; Lesueur F; Tavtigian SV
Breast Cancer Res; 2014 Jun; 16(3):R58. PubMed ID: 24894818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
